Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 28101-28110 Newer>

The Motley Fool January 16, 2008 Rick Aristotle Munarriz	You Can Go Home Again Even if the real estate market market isn't abuzz with activity, real estate websites certainly are.
The Motley Fool January 16, 2008 Matt Koppenheffer	JPMorgan Chase Is Singing in the Rain For the fourth quarter, the company's bottom line was solidly in the black, to the tune of $3 billion.
The Motley Fool January 16, 2008 Anders Bylund	The Sun Sets on MySQL Platform specialist Sun Microsystems ponied up $1 billion in cash and assumed options to buy privately held MySQL AB, taking its first step into the database sector.
The Motley Fool January 16, 2008 Brian Lawler	More Tysabri on the Way Biogen and Elan receive an additional approval for Tysabri. Investors, take note.
The Motley Fool January 16, 2008 Mac Greer	Fool Video: Chipotle vs. Starbucks vs. Whole Foods In this video the relative merits of Chipotle Mexican Grill, Starbucks, and Whole Foods are evaluated.
The Motley Fool January 16, 2008 Tim Beyers	Jobs Doesn't Wow? Wonderful! Investors remain unconvinced that Apple could be worth owning. They couldn't be more wrong. With just one business -- the iPhone -- Apple is on pace to double in size over the next five years.
The Motley Fool January 16, 2008 Emil Lee	US Bancorp Unfazed by Credit Crisis In the fourth quarter US Bancorp produces steady results once again, remaining relatively unscathed by the treacherous credit environment.
The Motley Fool January 16, 2008 Rick Aristotle Munarriz	Mr. Softy Meets Edgar Microsoft strikes an online deal with financial filings specialist EDGAR Online.
The Motley Fool January 16, 2008 Rich Duprey	Lawyers Hit a Brick Wall in StoneRidge Supreme Court rules against trial attorneys' bid to sue third parties.
The Motley Fool January 16, 2008 Brian Lawler	Another Inhalable Insulin Bites the Dust Novo Nordisk discontinues development of its troubled diabetes treatment and settles its patent infringement lawsuit against Pfizer. Investors, take note.
<Older 28101-28110 Newer> Return to current articles.